Net profit of Novartis India rose 7.30% to Rs 27.62 crore in the quarter ended June 2025 as against Rs 25.74 crore during the previous quarter ended June 2024. Sales declined 5.14% to Rs 87.55 crore in the quarter ended June 2025 as against Rs 92.29 crore during the previous quarter ended June 2024.
| Particulars | Quarter Ended |
| Jun. 2025 | Jun. 2024 | % Var. |
| Sales | 87.55 | 92.29 | -5 |
| OPM % | 31.11 | 25.97 | - |
| PBDT | 37.75 | 34.23 | 10 |
| PBT | 37.22 | 33.68 | 11 |
| NP | 27.62 | 25.74 | 7 |